LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein

2023 | journal article. A publication with affiliation to the University of Göttingen.

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein​
Shilts, J.; Crozier, T. W. M.; Teixeira-Silva, A.; Gabaev, I.; Gerber, P. P.; Greenwood, E. J. D. & Watson, S. J. et al.​ (2023) 
PLoS Biology21(2) art. e3001959​.​ DOI: https://doi.org/10.1371/journal.pbio.3001959 

Documents & Media

License

GRO License GRO License

Details

Authors
Shilts, Jarrod; Crozier, Thomas W. M.; Teixeira-Silva, Ana; Gabaev, Ildar; Gerber, Pehuén Pereyra; Greenwood, Edward J. D.; Watson, Samuel James; Ortmann, Brian M.; Gawden-Bone, Christian M.; Pauzaite, Tekle
Abstract
The interactions between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and human host factors enable the virus to propagate infections that lead to Coronavirus Disease 2019 (COVID-19). The spike protein is the largest structural component of the virus and mediates interactions essential for infection, including with the primary angiotensin-converting enzyme 2 (ACE2) receptor. We performed two independent cell-based systematic screens to determine whether there are additional proteins by which the spike protein of SARS-CoV-2 can interact with human cells. We discovered that in addition to ACE2, expression of LRRC15 also causes spike protein binding. This interaction is distinct from other known spike attachment mechanisms such as heparan sulfates or lectin receptors. Measurements of orthologous coronavirus spike proteins implied the interaction was functionally restricted to SARS-CoV-2 by accessibility. We localized the interaction to the C-terminus of the S1 domain and showed that LRRC15 shares recognition of the ACE2 receptor binding domain. From analyzing proteomics and single-cell transcriptomics, we identify LRRC15 expression as being common in human lung vasculature cells and fibroblasts. Levels of LRRC15 were greatly elevated by inflammatory signals in the lungs of COVID-19 patients. Although infection assays demonstrated that LRRC15 alone is not sufficient to permit viral entry, we present evidence that it can modulate infection of human cells. This unexpected interaction merits further investigation to determine how SARS-CoV-2 exploits host LRRC15 and whether it could account for any of the distinctive features of COVID-19.
Issue Date
2023
Journal
PLoS Biology 
Organization
Deutsches Primatenzentrum 
eISSN
1545-7885
Language
English
Sponsor
Wellcome Trust http://dx.doi.org/10.13039/100004440
Wellcome Trust http://dx.doi.org/10.13039/100004440
Pfizer UK http://dx.doi.org/10.13039/100009032
Wellcome Trust http://dx.doi.org/10.13039/100004440
Medical Research Council http://dx.doi.org/10.13039/501100000265
National Institute for Health Research http://dx.doi.org/10.13039/501100000272
Addenbrooke’s Charitable Trust, Cambridge University Hospitals http://dx.doi.org/10.13039/501100002927
Medical Research Council http://dx.doi.org/10.13039/501100000265
Wellcome Trust http://dx.doi.org/10.13039/100010269
NHS Blood and Transplant http://dx.doi.org/10.13039/100009033
Addenbrooke’s Charitable Trust, Cambridge University Hospitals http://dx.doi.org/10.13039/501100002927
NIHR Cambridge Biomedical Research Centre http://dx.doi.org/10.13039/501100018956
NIHR Cambridge Biomedical Research Centre

Reference

Citations


Social Media